FR Pharma Consulting ApS: Financial statements 2025
CVR: 44253569
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
FR Pharma Consulting ApS (CVR 44253569) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,566,086 and a net result of DKK 654,878 compared with DKK 203,351 the year before. That is an increase of 108.8% compared with the year before. Equity in the 2025 report amounted to DKK 898,229. The solvency ratio was 68.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,566,086
- Profit/Loss
- DKK 654,878
- Equity
- DKK 898,229
- Total Assets
- DKK 1,307,430
- Employees
- 1
Official annual report
How creditworthy is FR Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout FR Pharma Consulting ApS
FR Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Ferhat Celik. The company is owned by FR Pharma ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 424,639 and a net result of DKK -336,968 compared with DKK 654,878 the year before. Equity in the 2026 report amounted to DKK 561,263.